Log in to save to my catalogue

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Trans...

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Trans...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be9ce951a83742f28394dac5a80914cd

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac

About this item

Full title

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac

Publisher

Switzerland: MDPI AG

Journal title

Viruses, 2023-07, Vol.15 (7), p.1534

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

We evaluated neutralizing antibodies against the Omicron variant and Anti-Spike IgG response in solid organ (SOT) or hematopoietic stem cell (HSTC) recipients after a third dose of BNT162b2 (BNT) or CoronaVac (CV) following two doses of CV. In total, 95 participants underwent SOT (n = 62; 44 liver, 18 kidney) or HSCT (n = 27; 5 allogeneic, 22 autol...

Alternative Titles

Full title

BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_be9ce951a83742f28394dac5a80914cd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_be9ce951a83742f28394dac5a80914cd

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v15071534

How to access this item